Where does ESBATech, an Alcon Biomedical Research Unit LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), ESBATech, an Alcon Biomedical Research Unit LLC ranks #13,413 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does ESBATech, an Alcon Biomedical Research Unit LLC hold?

ESBATech, an Alcon Biomedical Research Unit LLC holds 22 US utility patents granted between 2015 and 2019, spanning 8 technology areas.

What is ESBATech, an Alcon Biomedical Research Unit LLC's Innovation Score?

ESBATech, an Alcon Biomedical Research Unit LLC has an Innovation Score of 27.1 out of 100 (22nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does ESBATech, an Alcon Biomedical Research Unit LLC focus on?

ESBATech, an Alcon Biomedical Research Unit LLC's top technology area is C07K (Peptides) with 22 patents, ranking #442 of 3,615 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is ESBATech, an Alcon Biomedical Research Unit LLC's patent grant rate increasing or decreasing?

ESBATech, an Alcon Biomedical Research Unit LLC's recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for ESBATech, an Alcon Biomedical Research Unit LLC's patents?

ESBATech, an Alcon Biomedical Research Unit LLC's patents average 10.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

ESBATech, an Alcon Biomedical Research Unit LLC

Q: How is the ESBATech, an Alcon Biomedical Research Unit LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 22 granted patents across 8 technology areas, recorded in grant years 2015–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Esbatech ranks #13,413 of 49,997 tracked US assignees by granted-patent volume, with 22 patents across 8 technology areas.

#13,413
of 49,997 US assignees by volume: 22nd percentile
by Innovation Score (27.1/100): 10.4
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13413 · Foreign Corporation #13,413 · 22 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 22 grants
MID-PACK #13,413/49,997
PHOTO-FINISH Eberhard Karls…
CPC-NARROW C07K · 8 areas
INNOV-THIN 27.1/100
CLAIMS-PAR 10.4 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Esbatech’s 27.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.8 pts (40%) Velocity 0.0 pts (0%) Breadth 10.0 pts (37%) Claim depth 6.2 pts (23%)

Qualcomm Incorporated · highest

85
ESBATech an Alcon… · this assignee

27
3D Lighting… · lowest

7

What this shows Esbatech's Innovation Score is 27.1/100 (22nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Esbatech?

Each dot is one of Esbatech’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Esbatech’s own 10.4 claims/patent is at or below the 13.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Esbatech vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Esbatech's grants concentrate

ESBATech, an Alcon Biomedical Research Unit LLC is a focused PatentsView assignee: 8 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2018 (9 grants) versus a trough of 1 in 2019. By volume, Esbatech sits between Emtensor GMBH and Element Energy, Inc..

Emtensor

22
Enterpriseweb

22
Enzychem Lifescie…

22
Erni Production &…

22
Eberhard Karls Un…

22
Edmonds Outdoors

22
Element 1

22
Element Energy

22
Esbatech an Alcon… ◀

22

What this shows ESBATech holds 22 patents at rank #13,401, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near ESBATech

By rank, the assignees closest to #13,401 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in ESBATech's primary technology class.

Esbatech's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

27 22nd percentile higher than 22% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

ESBATech, an Alcon Biomedical Research Unit LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	13.6%
2016	5	22.7%
2017	4	18.2%
2018	9	40.9%
2019	1	4.5%

Which technologies does ESBATech, an Alcon Biomedical Research Unit LLC patent most?

C07K - Peptides 22

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 17

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 11

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 2

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

ESBATech, an Alcon Biomedical Research Unit LLC's patent record in context - here's where to go next.

ESBATech, an Alcon Biomedical Research Unit LLC's lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #13,413 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare ESBATech, an Alcon Biomedical Research Unit LLC against Emtensor GMBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.